|
RMN is Reader Supported
Our Goal for DEC 8 - JAN 5:
$1,450
Click Widget or Click Here to contribute.
Checks & Money Orders:
Raye Allan Smith
P.O. Box 95
Ashtabula, OH 44005
Users Online: 55
Who Founded
RMNews?
Dewitt Jones' Video

"Celebrate What's Right With The World"
"When the Starships Fly!"
Listen at YouTube
The
Theme for The Obergon Chronicles
Listen at YouTube
The Obergon Chronicles ebook
RUMOR MILL NEWS RADIO
CGI ROOM Common Ground Independent Media
WHAT ARE THE FACTIONS?
THE AMAZING RAYELAN ALLAN
BIORHYTHMS
LOTTO PICKS
OTHER WAYS TO DONATE
RUMOR MILL NEWS AGENTS WHO'VE BEEN INTERVIEWED ON RUMOR MILL NEWS
RADIO ______________
NOVEMBER 2008
Kevin Courtois - Kcbjedi
______________
Dr Robin Falkov
______________
Melinda Pillsbury Hr1
Melinda Pillsbury Hr2
______________
Daneen Peterson
______________
Daneen Peterson
______________
Disclosure Hr1
Disclosure Hr2
______________
Scribe
______________
in_PHI_nitti
______________
Jasmine Hr1
Jasmine Hr2
______________
Tom Chittum Hr1
Tom Chittum Hr2
______________
Kevin Courtois
______________
Dr Syberlux
______________
Gary Larrabee Hr1
Gary Larrabee Hr2
______________
Kevin Courtois
______________
Pravdaseeker Hr1
Pravdaseeker Hr2
______________
DECEMBER 2008
Tom Chittum
______________
Crystal River
______________
Stewart Swerdlow Hr1
Stewart Swerdlow Hr2
______________
Janet Swerdlow Hr1
Janet Swerdlow Hr2
______________
Dr. Robin Falkov Hr1
Dr. Robin Falkov Hr2
Dr. Robin Falkov Hr3
JANUARY 2009
______________
Patriotlad
______________
Patriotlad
______________
Crystal River
______________
Patriotlad
______________
Dr. Robin Falcov
______________
Patriotlad
FEBRUARY 2009
|
Find UFOs, The Apocalypse, New World Order, Political Analysis,
Alternative Health, Armageddon, Conspiracies, Prophecies,
Spirituality, Home Schooling, Home Mortgages and more, in:
Rumor Mill News Reading Room, Current Archive
More on.... UK first country to approve dual-strain vaccine - after INITIAL findings
Posted By: Namaste Date: Thursday, 18-Aug-2022 15:32:23
www.rumormill.news/205881
Date 17.8.2022 20:44
Contact photo
Message Body
Houston, TX - Apr 18, 2022
The study vaccines included in this first stage of the trial are manufactured by Moderna, Inc., based in Cambridge, Mass. The trial will be adapted to enroll more participants to evaluate additional vaccine platforms and variant vaccines from other manufacturers as needed to further inform public health decisions.
Participants will be monitored for symptoms and adverse events following vaccination and will be asked to return to the clinic during set times over the course of 12-14 months to provide blood samples. Investigators will evaluate the samples in the laboratory to measure and characterize immune responses to SARS-CoV-2 strains. Investigators aim to have initial findings available by August 2022 - AFTER ONLY FOUR MONTHS, released in the UK....
Is this the winter 'flu jab then, classed as a covid booster, with mRNA after only initial findings of four months testing in phase 2.
This bivalent vaccine has an important role to play in protecting people in the U.K. from Covid-19 as we enter the winter months.
https://www.cnbc.com/2022/08/15/uk-becomes-first-country-to-approve-modernas-dual-covid-19-vaccine.html
Moderna's latest vaccine, called Spikevax, targets both the original strain and the first Omicron variant (BA.1), which emerged last winter. It is known as a bivalent vaccine as it takes aim at two forms of COVID.??? But spikevax is not new...it's been 'adapted'..
Sent Monday, 15 August 2022 at 21:53:16 BST
Subject: Covid: UK first country to approve dual-strain vaccine - BBC News
https://www.bbc.co.uk/news/health-62548336
|
RMN is an RA production.
|
The only pay your RMN moderators receive comes from ads.
If you're using an ad blocker, please consider putting RMN in your ad blocker's whitelist.
Serving Truth and Freedom
Worldwide since 1996
Politically Incorrect News
Stranger than Fiction
Usually True!
Click Widget or Click Here to contribute.

^
AGENTS WEBPAGES
Provided free to RMN Agents
^
AGENTS WEBPAGES
Provided free to RMN Agents
|